Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

A group of highly experienced researchers at VCU Massey Comprehensive Cancer Center was awarded more than $13 million through ...

A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that ...

2024 — As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of ...

The liver filters toxins, aids digestion, and supports the immune system. Liver cancer disrupts these functions, making early ...

Unfortunately, this exquisite organ can be impacted by primary liver cancer originating within itself or by secondary cancer ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

Duke-NUS alumnus Dr Marjorie Hoang (Class of 2023) and her mentor, Professor Pierce Chow, have brought clarity to the complex decision-making process patients diagnosed with intermediate-stage liver ...

This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a study from EPFL ..